Neuren Pharmaceuticals Management
Management criteria checks 3/4
Neuren Pharmaceuticals' CEO is Jon Pilcher, appointed in May 2020, has a tenure of 4.33 years. total yearly compensation is A$1.36M, comprised of 40.2% salary and 59.8% bonuses, including company stock and options. directly owns 0.31% of the company’s shares, worth €3.76M. The average tenure of the management team and the board of directors is 4.2 years and 6.2 years respectively.
Key information
Jon Pilcher
Chief executive officer
AU$1.4m
Total compensation
| CEO salary percentage | 40.2% |
| CEO tenure | 4.3yrs |
| CEO ownership | 0.3% |
| Management average tenure | 4.2yrs |
| Board average tenure | 6.2yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | AU$117m |
| Mar 31 2024 | n/a | n/a | AU$137m |
| Dec 31 2023 | AU$1m | AU$549k | AU$157m |
| Sep 30 2023 | n/a | n/a | AU$106m |
| Jun 30 2023 | n/a | n/a | AU$55m |
| Mar 31 2023 | n/a | n/a | AU$28m |
| Dec 31 2022 | AU$546k | AU$396k | AU$184k |
| Sep 30 2022 | n/a | n/a | -AU$3m |
| Jun 30 2022 | n/a | n/a | -AU$7m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | AU$432k | AU$203k | -AU$8m |
Compensation vs Market: Jon's total compensation ($USD942.20K) is below average for companies of similar size in the German market ($USD1.55M).
Compensation vs Earnings: Jon's compensation has increased by more than 20% in the past year.
CEO
Jon Pilcher
4.3yrs
Tenure
AU$1,364,404
Compensation
Mr. Jonathan Charles Pilcher, also known as Jon, BSc (Hons), ACA, FCA serves as Managing Director & Executive Director at Neuren Pharmaceuticals Limited since June 14, 2021. He had been a Company Secretary...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Executive Director | 4.3yrs | AU$1.36m | 0.31% A$ 3.8m | |
| CFO & Company Secretary | 4.1yrs | no data | no data | |
| Chief Science Officer | 20.7yrs | no data | no data | |
| Vice President of Corporate Development | no data | no data | no data | |
| Chief Medical Officer | 2.2yrs | no data | no data |
4.2yrs
Average Tenure
Experienced Management: NK9's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Executive Director | 3.3yrs | AU$1.36m | 0.31% A$ 3.8m | |
| Independent Non-Executive Director | 6.2yrs | AU$75.00k | 0.023% A$ 283.3k | |
| Independent Non-Executive Director | 6.2yrs | AU$75.00k | 0.023% A$ 280.2k | |
| Independent Non-Executive Chairman | 6.2yrs | AU$125.00k | 0.21% A$ 2.5m | |
| Independent Non-Executive Director | 1.5yrs | AU$62.50k | 0.017% A$ 202.2k |
6.2yrs
Average Tenure
Experienced Board: NK9's board of directors are considered experienced (6.2 years average tenure).